Trump targets Harvard in Title VI civil rights suit

The Trump administration filed a lawsuit against Harvard University on Friday, claiming the university failed to protect Jewish students since the Israel-Gaza War broke out, The New York Times reports.

(Wylie Poon via Flickr Creative Commons)

The Trump administration accused Harvard of “turn[ing] a blind eye to antisemitism and discrimination against Jews and Israelis.” While the administration admits Harvard strictly enforces policies against other biases, the lawsuit asserts that anti-Israel protesters violated rules “with impunity” by occupying buildings and harassing students after the war in Gaza in 2023.

This is essentially a Title VI complaint, which requires the plaintiff to show that the university acted with “deliberate indifference” toward those accused of antisemitism. But the university responded to The Hill:

“Harvard has taken substantive, proactive steps to address the root causes of antisemitism and actively enforces anti-harassment and anti-discrimination rules and policies on campus,” a Harvard spokesperson said in a statement. “Harvard’s efforts demonstrate the very opposite of deliberate indifference.”

The stakes are immense: the government is not only seeking a court-ordered independent monitor to oversee campus policies but is also attempting to recover billions of dollars in federal research grants. University leaders warn that the money is vital for medical breakthroughs in cancer and heart disease.

Editorial: Research over Retaliation

The defining tension of this legal saga is the thin line between ensuring student safety and protecting the freedom to criticize foreign policy. Democracy relies on the ability of its citizens (and its premier academic institutions) to debate the actions of any government without such speech being conflated with hatred toward a people. When criticism of military policy is categorized as antisemitism, the primary victims are nuance and open dialogue.

Furthermore, this protracted “all-out feud” between the administration and Harvard serves as a dangerous distraction for a global research hub. Every dollar spent on litigating what the university calls “pretextual” claims is a dollar diverted from the classrooms and laboratories that define Harvard’s mission. Using federal funding as a “payout” or a weapon of compliance risks halting life-saving scientific innovation midstream, a cost that far outweighs the perceived political gains of the moment.